Citius Pharmaceuticals, Inc. short interest in 2022
In 2022, Citius Pharmaceuticals, Inc.'s disclosed short interest ran from 7.75% of shares outstanding on 14 Jan 2022 to 7.50% on 30 Dec 2022, a change of -0.25 percentage points. The year's high was 10.26% on 31 May 2022 and its low 6.12% on 28 Feb 2022, averaging 7.57% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 31.17 days on 15 Nov 2022. Full history: Citius Pharmaceuticals, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 7.75% (14 Jan 2022)
- End of year
- 7.50% (30 Dec 2022)
- Change
- -0.25 pp
- High
- 10.26% (31 May 2022)
- Low
- 6.12% (28 Feb 2022)
- Average
- 7.57%
- Highest days to cover
- 31.17 (15 Nov 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 7.75% | 10.02 | |
| 31 Jan 2022 | 7.34% | 6.77 | |
| 15 Feb 2022 | 6.89% | 8.32 | 10-Q filed, results (8-K) |
| 28 Feb 2022 | 6.12% | 6.18 | |
| 15 Mar 2022 | 6.22% | 8.98 | |
| 31 Mar 2022 | 6.38% | 6.28 | |
| 14 Apr 2022 | 7.24% | 4.07 | |
| 29 Apr 2022 | 9.06% | 4.78 | |
| 13 May 2022 | 9.58% | 5.85 | 10-Q filed, results (8-K) |
| 31 May 2022 | 10.26% | 10.74 | |
| 15 Jun 2022 | 9.99% | 13.44 | |
| 30 Jun 2022 | 7.08% | 4.56 | |
| 15 Jul 2022 | 7.15% | 22.62 | |
| 29 Jul 2022 | 6.81% | 13.75 | |
| 15 Aug 2022 | 6.76% | 11.37 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 6.90% | 20.16 | |
| 15 Sep 2022 | 7.14% | 20.04 | |
| 30 Sep 2022 | 7.60% | 15.20 | |
| 14 Oct 2022 | 7.59% | 24.54 | |
| 31 Oct 2022 | 7.36% | 25.32 | |
| 15 Nov 2022 | 7.46% | 31.17 | |
| 30 Nov 2022 | 7.80% | 26.32 | |
| 15 Dec 2022 | 7.75% | 28.52 | |
| 30 Dec 2022 | 7.50% | 11.84 | 10-K filed, results (8-K) |
See also: Citius Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.